Molecular Mechanisms Involved in the Synergistic Activation of Soluble Guanylyl Cyclase by YC-1 and Nitric Oxide in Endothelial Cells

Abstract

YC-1 is a direct activator of soluble guanylyl cyclase (sGC) and sensitizes the enzyme for activation by nitric oxide (NO) and CO. Because the potentiating effect of YC-1 on NO-induced cGMP formation in platelets and smooth muscle cells has been shown to be substantially higher than observed with the purified enzyme, the synergism between heme ligands and YC-1 is apparently more pronounced in intact cells than in cell-free systems. Here, we investigated the mechanisms underlying the synergistic activation of sGC by YC-1 and NO in endothelial cells. Stimulation of the cells with YC-1 enhanced cGMP accumulation up to ∼100-fold. The maximal effect of YC-1 was more pronounced than that of the NO donor DEA/NO (∼20-fold increase in cGMP accumulation) and markedly diminished in the presence ofl-NG-nitroarginine, EGTA, or oxyhemoglobin. Because YC-1 did not activate endothelial NO synthase, the pronounced effect of YC-1 on cGMP accumulation was apparently caused by a synergistic activation of sGC by YC-1 and basal NO. The effect of YC-1 was further enhanced by addition of DEA/NO, resulting in a ∼160-fold stimulation of cGMP accumulation. Thus, YC-1 increased the NO-induced accumulation of cGMP in intact cells by ∼8-fold. Addition of endothelial cell homogenate increased the stimulatory effect of YC-1 on NO-activated purified sGC from 1.2- to 3.7-fold. This effect was not observed with heat-denatured homogenates, suggesting that a heat-labile factor present in endothelial cells potentiates the effect of YC-1 on NO-activated sGC.

Footnotes

  • Send reprint requests to: Dr. Kurt Schmidt, Institut für Pharmakologie und Toxikologie, Karl-Franzens-Universität Graz, Universitätsplatz 2, A-8010 Graz, Austria. E-mail: kurt.schmidt{at}kfunigraz.ac.at

  • This work was supported by Austrian Science Fund Grants P12191 (to K.S.) and P13586 (to B.M.).

  • Abbreviations:
    sGC
    soluble guanylyl cyclase
    NO
    nitric oxide
    NOS
    nitric-oxide synthase
    eNOS
    endothelial nitric-oxide synthase
    PDE
    phosphodiesterase
    DMSO
    dimethyl sulfoxide
    IBMX
    3-isobutyl-1-methylxanthine
    l-NNA
    l-NG-nitroarginine
    OxyHb
    oxyhemoglobin
    DEA/NO
    2,2-diethyl-1-nitroso-oxyhydrazine
    • Received May 22, 2000.
    • Accepted October 11, 2000.
« Previous | Next Article »Table of Contents